Evidence map›Paper›PMID 20554861›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2010

Modulations of NeuroD activity contribute to the differential effects of morphine and fentanyl on dendritic spine stability.

Hui Zheng, Yan Zeng, Ji Chu, Angel YuetFang Kam, Horace H Loh, Ping-Yee Law

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. miR-190-5p in human diseases.Cancer cell international · 2019
    Review
  10. Review
  11. Article
  12. Mechanisms regulating dendritic arbor patterning.Cellular and molecular life sciences : CMLS · 2017
    Review
  13. Review
  14. Review
  15. Article
  16. Morphine-Associated Contextual Cues Induce Structural Plasticity in Hippocampal CA1 Pyramidal Neurons.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Article
  17. Effects of addictive drugs on adult neural stem/progenitor cells.Cellular and molecular life sciences : CMLS · 2016
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hui ZhengDepartment of Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455-0217, USA. zhenhui2055@hotmail.com
Yan Zeng
Ji Chu
Angel YuetFang Kam
Horace H Loh
Ping-Yee Law
University of Minnesota · USTwin Cities Orthopedics · US

Funding

Subcellular Targeting/Packaging of Opioids/ReceptorsP50DA011806 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI WICKMAN, KEVIN D · 1998 to 2012
$14.0M
Structural and Functions Studies of Mu Opiate Receptors: Regulation of its GeneR01DA001583 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LOH, HORACE · 1985 to 2017
$6.5M
NEUROCHEMICAL BASIS ON NARCOTIC ADDICTIONR01DA000564 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LOH, HORACE · 1985 to 2010
$5.1M
G-PROTEINS AND OPIOID RECEPTOR FUNCTIONSR01DA007339 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LAW, PING-YEE · 1991 to 2008
$2.5M
Engineered Opioid Receptors as Therapeutic Agents for Pain ControlR01DA023905 · NIDA · UNIVERSITY OF MINNESOTA · PI LAW, PING-YEE · 2008 to 2012
$2.1M
NEURONAL REGULATION OF OPIOID RECEPTOR TRAFFICKINGR01DA016674 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LAW, PING-YEE · 2004 to 2008
$1.4M
G PROTEINS AND OPIOID RECEPTOR FUNCTIONSK05DA000513 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LAW, PING-YEE · 2001 to 2010
$1.2M
NEUROCHEMICAL MECHANISM OF NARCOTIC ACTIONSK05DA070554 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LOH, HORACE · 1985 to 2008
$1.1M
Neurochemical Basis of Opiate AddictionR56DA000564 · NIDA · UNIVERSITY OF MINNESOTA · PI LAW, PING-YEE, LOH, HORACE · 2012 to 2013
$329k
NIDA NIH HHS DA000564NIDA NIH HHS DA007339NIDA NIH HHS DA011806NIDA NIH HHS DA016674NIDA NIH HHS K05 DA000513NIDA NIH HHS K05-DA00513NIDA NIH HHS K05 DA070554NIDA NIH HHS K05-DA70544NIDA NIH HHS P50 DA011806NIDA NIH HHS R01 DA000564NIDA NIH HHS R01 DA001583NIDA NIH HHS R01 DA007339NIDA NIH HHS R01 DA016674NIDA NIH HHS R01 DA023905NIDA NIH HHS R56 DA000564
6 · The paper itself

Abstract

The cellular level of neurogenic differentiation 1 (NeuroD) is modulated differentially by mu-opioid receptor agonists; fentanyl increases NeuroD level by reducing the amount of microRNA-190 (miR-190), an inhibitor of NeuroD expression, whereas morphine does not alter NeuroD level. In the current study, NeuroD activity was demonstrated to be also under agonist-dependent regulation. After 3 d of treatment, morphine and fentanyl decreased the activity of the Ca(2+)/calmodulin-dependent protein kinase II alpha (CaMKIIalpha), which phosphorylates and activates NeuroD. Because NeuroD activity is determined by both the CaMKIIalpha activity and the cellular NeuroD level, the overall NeuroD activity was reduced by morphine, but maintained during fentanyl treatment. The differential effects of agonists on NeuroD activity were further confirmed by measuring the mRNA levels of four NeuroD downstream targets: doublecortin, Notch1, neurogenic differentiation 4, and Roundabout 1. Decreased dendritic spine stability and mu-opioid receptor signaling capability were also observed when NeuroD activity was attenuated by miR-190 overexpression or treatment with KN93, a CaMKIIalpha inhibitor. The decrease could be rescued by NeuroD overexpression, which restored NeuroD activity to the basal level. Furthermore, elevating NeuroD activity attenuated the morphine-induced decrease in dendritic spine stability. Therefore, by regulating NeuroD activity, mu-opioid receptor agonists modulate the stability of dendritic spines.

Indexed as

NeuronsAnimalsBasic Helix-Loop-Helix ProteinsBenzylaminesCalcium-Calmodulin-Dependent Protein Kinase Type 2Cells, CulturedDendritic SpinesDose-Response Relationship, DrugDoublecortin Domain ProteinsDoublecortin ProteinEnzyme InhibitorsFentanylGene Expression RegulationGreen Fluorescent ProteinsHippocampusMicrotubule-Associated ProteinsBasic Helix-Loop-Helix ProteinsBenzylaminesCalcium-Calmodulin-Dependent Protein Kinase Type 2Dcx protein, ratDoublecortin Domain ProteinsDoublecortin Proteinenhanced green fluorescent proteinEnzyme InhibitorsFentanylGreen Fluorescent ProteinsKN 92Microtubule-Associated ProteinsMorphineNarcoticsNerve Tissue ProteinsNeurod1 protein, ratNeuropeptidesNotch1 protein, ratOprm1 protein, ratReceptor, Notch1Receptors, ImmunologicReceptors, Opioid, muRNA, MessengerRoundabout ProteinsSulfonamides

Identifiers

PMID20554861
PMCPMC2913383
OpenAlexW2002796324

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.